Water Island Capital’s Alder Biopharmaceuticals ALDR Stock Holding History

Water Island Capital’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-505,250	Closed	-$9.53M	–	113
2019 Q3	$9.53M	Buy	+505,250	New	+$5.78M	0.59%	29

Water Island Capital's ALDR Position: Q4 2019 in Review

Water Island Capital sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 505,250 shares — an estimated $9.53M sold.

Water Island Capital first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $9.53M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Water Island Capital reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Water Island Capital sold 505,250 Alder Biopharmaceuticals shares in Q4 2019, an estimated $9.53M.
Water Island Capital first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Water Island Capital's Alder Biopharmaceuticals position peaked at $9.53M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Water Island Capital's 13F filing for Q4 2019, filed 11 Feb 2020.